Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 11, Number 10—October 2005
Research

Vancomycin and Home Health Care

Thomas G. Fraser*1, Valentina Stosor*, Qiong Wang†, Anne Allen‡, and Teresa R. Zembower*Comments to Author 
Author affiliations: *Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA; †University of Illinois at Chicago School of Public Health, Chicago, Illinois, USA; ‡Northwestern Memorial Hospital, Chicago, Illinois, USA

Main Article

Table 4

Infection diagnoses in patients referred for home infusions of vancomycin

Diagnosis* Use per guidelines, no. (%), N = 180 Use outside guidelines, no. (%), N = 116 p value†
Skin or soft tissue infection 89 (49.4) 51 (44.0) 0.356
Osteomyelitis or septic arthritis 30 (16.7) 25 (21.6) 0.294
Postoperative wound infection 38 (21.1) 19 (16.4) 0.310
Orthopedic device-related infection 5 (2.8) 7 (6.0) 0.227
Central nervous system infection‡ 3 (1.7) 6 (5.2) 0.161
Urinary tract infection 36 (20.0) 13 (11.2) 0.042
Pneumonia 9 (5.0) 1 (0.9) 0.095
Bloodstream infection 61 (33.9) 16 (13.8) <0.001
Vascular device infection 21 (11.7) 10 (8.6) 0.398
Infective endocarditis 8 (4.4) 5 (4.3) 0.956

*Some patients had >1 diagnosis.
†Values <0.05 were considered significant.
‡Includes shunt infections.

Main Article

1Current affiliation: Cleveland Clinic Foundation, Cleveland, Ohio, USA

Page created: February 22, 2012
Page updated: February 22, 2012
Page reviewed: February 22, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external